2010

December

• Outcomes after recurrence of oral cancer vary by timing, site -

• Most patients can speak and swallow after combination treatment for head and neck cancer -

• About one-fifth of women, less than 7 percent of men report use of indoor tanning -

• Racial disparities evident in early-stage liver cancer survival -

• Blacks with Liver Cancer More Likely to Die -

• Robotic Surgery for Head and Neck Cancer Shows Promise -

• Intensive Chemotherapy Can Dramatically Boost Survival of Older Teenage Leukemia Patients -

• Finnish researchers find a compound that prevents the growth of prostate cancer cells -

• Electronic nose detects cancer -

• Genome code cracked for most common form of pediatric brain cancer -

• Lung cancer screen: a license to smoke? -

• Scientists discover powerful biomarker panel for the early detection of breast cancer -

• Decades after Childhood Radiation, Thyroid Cancer a Concern -

• Liver cancer in cirrhotic patients effectively treated with radiofrequency ablation -

• deCODE discovers genetic markers that improve the power of PSA testing for detecting prostate cancer -

• Scientists decode secrets of a very common virus that can cause cancer -

• Novel therapy for metastatic kidney cancer developed at VCU Massey Cancer Center -

• Missing molecules hold promise of therapy for pancreatic cancer -

• A protein called cFLIP makes tumor cells in breast cancer resistant to treatments -

• Scientists identify how virus triggers cervical and mouth cancer -

• Alcohol and Cancer: Know Your Limit -

• Unique needs and outcomes of pregnant women with breast cancer identified -

• Novel imaging technique may reduce lymphedema in breast cancer patients -

• Higher co-payments increase chance of early discontinuation of breast cancer therapy -

• UCR scientists identify pomegranate juice components that could stop cancer from spreading -

• Ovarian cancer screening saves few lives -

• Biological diversity of ovarian cancer lessens value of screening -

• Roche drugs, chemo destroy 46 percent of breast tumors -

• Popular new breast cancer treatment lacks data -

• Phase III study compared neoadjuvant therapy with lapatinib or trastuzumab for early breast cancer -

• Combination therapy reduced HER2-positive breast cancers -

• Circulating tumor cells predicted recurrence, death in patients with early-stage breast cancer -

• High CTC levels predicted poor outcome in metastatic breast cancer -

• Poor breast cancer prognosis associated with presence of circulating tumor, cancer stem cells -

• Trio of drugs may combat ‘triple negative’ breast cancer -

• Simple fingertip test may identify breast cancer patients at risk for carpal tunnel syndrome -

• Drug combination shows promise for newly diagnosed blood cancer patients -

• Many U.S. women do not get recommended mammograms -

• Surgery Complications Linked to Chemotherapy Delay -

• For Women with Breast Cancer Gene, Psychological Factors Affect Choices about Risk-Reducing Surgery -

• Use of Low-Dose Aspirin Associated with Improved Performance of Test for Detecting Colorectal Cancer -

• Ultraviolet light helps skin cancer cells thrive, researchers report -

• Older men get less effective prostate cancer care -

• Tests between colonoscopies could be lifesaver for high-risk patients -

• Not Only Skin Deep: Penn Study on Skin Formation Suggests Strategies to Fight Skin Cancer -

• Breast CT imaging system marches forward as pain-free tool to aid mammograms -

• Widely Used Arthritis Pill Protects Against Skin Cancer -

• Genetic mutations associated with increased PSA and prostate cancer -

• Annual breast cancer screening beginning at age 40 reduces mastectomy risk -

• The protein TXNL2 provides human breast cancer cells with protection -

<< Back to main